Analyst firms · Mizuho · SBRA
Mizuho SBRA price target and rating history
Sabra Health Care REIT Inc. (SBRA) · Real Estate
Mizuho rates Sabra Health Care REIT Inc. (SBRA) Neutral with a $20 price target, as of its latest action on Dec 5, 2024. It has published 3 rating actions on SBRA since July 2021, including 1 upgrade and 1 downgrade. Across 3 firms with a SBRA price target in the last 12 months, the median target is $21.
- Current rating
- Neutral
- Price target
- $20
- Median target, all firms
- $21
- Actions on SBRA
- 3
Mizuho price target on SBRA
Every Mizuho rating on SBRA
- Dec 5, 2024
- May 25, 2022
- Jul 14, 2021
How other firms rate SBRA
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Huntington | Outperform | $23 | Sep 10, 2026 |
| Raymond James | Mkt Perform | Aug 6, 2026 | |
| Truist Securities | Hold | Jul 8, 2026 | |
| Barclays | Overweight | $21 | Jul 7, 2026 |
| Citigroup | Neutral | $19 | Jun 23, 2026 |
Questions about Mizuho and SBRA
- What is Mizuho's price target for SBRA?
- Mizuho's latest stated price target for Sabra Health Care REIT Inc. (SBRA) is $20, from its action on Dec 5, 2024.
- What is Mizuho's rating on SBRA?
- Mizuho rates SBRA Neutral, a neutral rating, as of Dec 5, 2024.
- When did Mizuho last change its view on SBRA?
- On Dec 5, 2024, Mizuho downgrades to Neutral from Outperform, price target $20.
- How does Mizuho's SBRA target compare with other analysts?
- Across 3 firms with a SBRA price target in the last 12 months, the median target is $21.
More SBRA rating histories
All Mizuho ratingsSBRA news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.